ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Here, L-fucose promoted the multimerization of adiponectin, which reduces the risk of metabolic syndrome-related morbidities such as non-alcoholic fatty liver disease (NAFLD) [27].